BioLife Solutions Inc (BLFS)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-20,184	-46,025	-73,454	-62,934	-66,427	-102,234	-83,419	-146,098	-139,805	-106,361	-95,965	-15,211	-8,908	4,025	2,813	-21,443	1,983	7,778	19,180	39,812
Revenue (ttm)	US$ in thousands	102,868	122,972	125,729	136,909	142,796	154,008	161,427	162,452	161,032	154,468	147,521	138,192	118,837	96,581	74,057	52,773	48,087	41,249	36,673	33,590
Net profit margin		-19.62%	-37.43%	-58.42%	-45.97%	-46.52%	-66.38%	-51.68%	-89.93%	-86.82%	-68.86%	-65.05%	-11.01%	-7.50%	4.17%	3.80%	-40.63%	4.12%	18.86%	52.30%	118.52%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-20,184K ÷ $102,868K
= -19.62%

Net profit margin is a key financial metric that indicates the percentage of revenue that translates into net profit after all expenses have been accounted for. A higher net profit margin is generally favorable as it suggests the company is efficient in managing its costs relative to its revenue.

Based on the data provided for BioLife Solutions Inc, the net profit margin has shown significant fluctuations over the quarters. It started at an exceptionally high level of 118.52% in March 2020, indicating that the company generated a significant profit relative to its revenue during that period. However, over the subsequent quarters, the net profit margin gradually decreased, turning negative by March 2021.

From March 2021 to December 2024, the net profit margin remained consistently negative, with fluctuations ranging from -89.93% to -19.62%. These negative values indicate that the company's expenses were exceeding its revenue, resulting in net losses during those periods.

Overall, the trend in the net profit margin for BioLife Solutions Inc reflects a decline in profitability over the quarters, with the company experiencing difficulty in generating net profit relative to its revenue and managing its expenses effectively. This may raise concerns about the company's financial health and operational efficiency during the period under review.